Stockreport

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical, Inc.  (VANI) 
PDF Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-a [Read more]